Showing results (1121-1130 of 1,181) with videos related to

Sort By:
Pageof 119
Research Square|May 19, 2025
Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX StudyAntonella Borgatti, Brian D Husbands, Aaron L Sarver, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 26, 2016
The rise of novelty in ecosystemsVolker C Radeloff, John W Williams, Brooke L Bateman, et al.
Frontiers in Oncology|November 28, 2022
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinomaDeepika Dhawan, José A Ramos-Vara, Sagar M Utturkar, et al.
Current Sports Medicine Reports|January 4, 2021
Recommended Musculoskeletal and Sports Medicine Model Curriculum for Emergency Medicine Residency TrainingYvonne C Chow, Anna L Waterbrook, Heidi N Suffoletto, et al.
American Journal of Medical Genetics|December 3, 1999
An autosomal genomic screen for autism. Collaborative linkage study of autismS Barrett, J C Beck, R Bernier, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of 4-(5-Membered)Heteroarylether-6-methylpicolinamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5Elizabeth S Childress, Rory A Capstick, Katherine E Crocker, et al.
Cell Metabolism|June 23, 2015
A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and HealthspanSebastian Brandhorst, In Young Choi, Min Wei, et al.
Redox Biology|November 20, 2019
Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stressFrances L Byrne, Ellen M Olzomer, Gabriella R Marriott, et al.
Journal of Medicinal Chemistry|October 17, 2025
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391)Motoyuki Tanaka, Yoko Sekioka, Gakuji Hashimoto, et al.
Cancer Research Communications|September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for OsteosarcomaEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Pageof 119